Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report
Müller E, Hillemacher T, Müller CP (2021)
Publication Type: Journal article
Publication year: 2021
Journal
Book Volume: 7
Article Number: e07039
Journal Issue: 5
DOI: 10.1016/j.heliyon.2021.e07039
Abstract
Background: Kratom is a psychoactive plant preparation originating from Southeast Asia. It has been used as a recreational and performance drug in Southeast Asia, and is now increasingly used in Europe and the U.S. Case report: We describe the case of a 63-year-old man who presented for treatment after his long-term Kratom use failed as a self-management for persistent major depression (ICD 10: F33.2) and a generalized anxiety disorder (ICD-10: F41.1). The failure coincided with emerging stress at the beginning of the COVID-19 pandemic. The patient suffered from childhood on from ruminative thinking and depressive mood, which was treated in several settings during his life. He started to use alcohol to control his depression, but developed an alcohol addiction. This was successfully treated and the patient remained abstinent for more than 25 years afterwards. About 7 years ago, he started to use Kratom 3–4 times daily on a regular, but constant rate. Kratom use worked efficiently as a self-management of his depression with no escalation of dosing. It was also very effective in reducing Morbus Menière symptoms of tinnitus and sudden hearing loss, which eventually allowed regular performance as a caregiver in a demanding job on shift-work. During recently increased stress load in the work environment and the COVID-19 pandemic, the established Kratom doses failed to control hyperarousal and mental nervousness. The patient was treatment seeking and subsequently detoxified from Kratom. Anxiety- and depression management was shifted to treatment attempts with Lorazepam, Venlafaxine, Opipramol, Mirtazapine and psychotherapy. Conclusion: Kratom instrumentalization for self-management of depression and anxiety may effectively work without causing escalation of drug use and addiction, but may be limited by a temporary increase in psychological stress load and a relapse into major depression and generalized anxiety disorder.
Authors with CRIS profile
Involved external institutions
Germany (DE)How to cite
APA:
Müller, E., Hillemacher, T., & Müller, C.P. (2021). Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report. Heliyon, 7(5). https://doi.org/10.1016/j.heliyon.2021.e07039
MLA:
Müller, Elisabeth, Thomas Hillemacher, and Christian P. Müller. "Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report." Heliyon 7.5 (2021).
BibTeX: Download